Skip to main content
. 2022 Jan 19;27(3):629. doi: 10.3390/molecules27030629

Figure 1.

Figure 1

Increase in PPARα, PPARγ and LXR activity in HepG2 (human hepatocellular carcinoma) cells. Fold induction of PPARα (A), PPARγ (B) and LXR (C) was determined by luciferase assay in cells treated with AF (12.5, 25, and 50 μg/mL), ciprofibrate (CIP10, 10 µM), rosiglitazone (ROS10, 10 μM) and T0901317 (T09, 1 µM). The data are presented as mean ± SEM of duplicates in three independent experiments. * p < 0.05 compared to DMSO.